Fig. 3From: The societal economic burden of autosomal dominant polycystic kidney disease in the United StatesIndirect costs from unemployment and reduced productivity at work. ADPKD: autosomal dominant polycystic kidney disease; CKD: chronic kidney disease; ESRD-RRT: end stage renal disease requiring renal replacement therapy; US: United States. Notes: 1. Excluding ESRD-RRT. 2. Unemployment-to-population ratio and average annual earnings in the US population were age-adjusted given the average age of working-age individuals in each of the ADPKD disease stages. 3. Employment-to-population ratio among individuals with ADPKD. 4. Productivity weight in employed individuals with ADPKD (based on Work Productivity and Activity Impairment [WPAI])Back to article page